Myron E Schwartz

Author PubWeight™ 62.54‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol 2008 5.93
2 Combining clinical, pathology, and gene expression data to predict recurrence of hepatocellular carcinoma. Gastroenterology 2011 2.66
3 Report of a national conference on liver allocation in patients with hepatocellular carcinoma in the United States. Liver Transpl 2010 2.57
4 Integrative molecular analysis of intrahepatic cholangiocarcinoma reveals 2 classes that have different outcomes. Gastroenterology 2013 2.42
5 Long-term results with multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinomas larger than 5 centimeters. Ann Surg 2002 2.14
6 A system of classifying microvascular invasion to predict outcome after resection in patients with hepatocellular carcinoma. Gastroenterology 2009 1.90
7 Recurrence of hepatocellular carcinoma after liver transplant: patterns and prognosis. Liver Transpl 2004 1.88
8 Hepatic resection for primary hepatolithiasis: a single-center Western experience. J Am Coll Surg 2012 1.70
9 Biliary complications in 96 consecutive right lobe living donor transplant recipients. Transplantation 2004 1.57
10 Liver transplantation for hepatocellular carcinoma. Ann Surg Oncol 2008 1.50
11 Clinical utility of AFP-L3% measurement in North American patients with HCV-related cirrhosis. Am J Gastroenterol 2007 1.49
12 Multicentric evaluation of a clinical and prognostic scoring system predictive of survival after resection of intrahepatic cholangiocarcinomas. Liver Int 2010 1.46
13 Accelerated hepatitis C virus kinetics but similar survival rates in recipients of liver grafts from living versus deceased donors. Hepatology 2005 1.44
14 Adult living donor liver transplantation for patients with hepatocellular carcinoma: extending UNOS priority criteria. Ann Surg 2004 1.36
15 Anatomic variations in right liver living donors. J Am Coll Surg 2004 1.33
16 Phase 1 study of concurrent sunitinib and image-guided radiotherapy followed by maintenance sunitinib for patients with oligometastases: acute toxicity and preliminary response. Cancer 2009 1.28
17 Utility of Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein and des-gamma-carboxy prothrombin, alone or in combination, as biomarkers for hepatocellular carcinoma. Clin Gastroenterol Hepatol 2008 1.26
18 Post-liver transplant acute renal failure: factors predicting development of end-stage renal disease. Clin Transplant 2004 1.17
19 Quality of life after lobectomy for adult liver transplantation. Transplantation 2002 1.15
20 Perioperative blood transfusion and long-term outcomes after resection of hilar cholangiocarcinoma. J Gastrointest Surg 2015 1.07
21 Fifteen-year, single-center experience with the surgical management of intrahepatic cholangiocarcinoma: operative results and long-term outcome. Surgery 2007 1.07
22 Hilar cholangiocarcinoma involving the portal vein bifurcation: long-term results after resection. J Hepatobiliary Pancreat Surg 2002 1.03
23 Aggressive surgical resection for hilar cholangiocarcinoma: is it justified? Audit of a single center's experience. Am J Surg 2008 1.02
24 Differences in surgical outcomes between hepatitis B- and hepatitis C-related hepatocellular carcinoma: a retrospective analysis of a single North American center. Ann Surg 2014 0.99
25 Hepatocellular carcinoma: a prime indication for living donor liver transplantation. J Gastrointest Surg 2002 0.94
26 Post-traumatic pseudoaneurysm of the common hepatic artery with duodenal fistula. HPB (Oxford) 2002 0.91
27 Resection of large hepatocellular carcinoma (≥10 cm): a unique western perspective. J Surg Oncol 2012 0.90
28 Ischemia time impacts recurrence of hepatocellular carcinoma after liver transplantation. Hepatology 2015 0.88
29 Does anatomic versus nonanatomic resection affect recurrence and survival in patients undergoing surgery for colorectal liver metastasis? Ann Surg Oncol 2008 0.86
30 Giant hemangioma of the adrenal. Isr Med Assoc J 2004 0.85
31 Actual 10-year survival following hepatectomy for hepatocellular carcinoma. HPB (Oxford) 2013 0.84
32 Invasive colloid carcinoma arising from intraductal papillary neoplasm in a 50-year-old woman with primary sclerosing cholangitis. Semin Liver Dis 2004 0.84
33 Right hepatectomy for living donation: role of remnant liver volume in predicting hepatic dysfunction and complications. Surgery 2013 0.83
34 Marked Differences in acute cellular rejection rates between living-donor and deceased-donor liver transplant recipients. Transplantation 2005 0.83
35 Surgical treatment of intrahepatic cholangiocarcinoma in the USA. J Hepatobiliary Pancreat Sci 2014 0.82
36 Recurrent hepatitis C after retransplantation: factors affecting graft and patient outcome. Liver Transpl 2005 0.82
37 An integrated approach to intestinal failure: results of a new program with total parenteral nutrition, bowel rehabilitation, and transplantation. J Gastrointest Surg 2002 0.82
38 Results of retransplantation for recurrent hepatitis C. Hepatology 2003 0.82
39 The role of fibrin sealants in hepatic surgery. Surg Technol Int 2007 0.81
40 Outcomes following resection of intrahepatic cholangiocarcinoma. HPB (Oxford) 2014 0.81
41 Diaphragmatic hernia after hepatic resection: case series at a single Western institution. J Gastrointest Surg 2012 0.81
42 Prognostic significance of lymph node metastases in small intestinal neuroendocrine tumors. Neuroendocrinology 2015 0.79
43 Liver transplantation for liver rupture due to light chain deposition disease: a case report. Semin Liver Dis 2006 0.78
44 Surgical resection for advanced gallbladder carcinoma. The Mount Sinai experience. Hepatogastroenterology 2011 0.78
45 Combined adult-to-adult living donor right lobe liver transplantation and pancreatoduodenectomy for distal bile duct adenocarcinoma in a patient with primary sclerosing cholangitis. J Am Coll Surg 2003 0.78
46 Advancing the diagnosis and treatment of hepatocellular carcinoma. Liver Transpl 2005 0.77
47 Syngeneic living-donor liver transplantation without the use of immunosuppression. Gastroenterology 2002 0.77
48 Functional abdominal complaints occurred frequently in living liver donors after donation. Scand J Gastroenterol 2010 0.76
49 Surgical management of hepatocellular carcinoma. Mt Sinai J Med 2012 0.76
50 Venous hemodynamics in living donor right lobe liver transplantation. Liver Transpl 2002 0.76
51 Expansion of criteria for transplanting patients with hepatocellular carcinoma. Liver Transpl 2008 0.75
52 Recurrent giant hemangiomas of liver: Report of two rare cases with literature review. World J Gastrointest Surg 2012 0.75